Nasdaq Brkr News Today

Bruker (NASDAQ:BRKR – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.79-2.84 for the period, compared to the consensus estimate of $2.71. The company issued revenue guidance of $3.29-3.35 billion, compared to the consensus revenue estimate of $3.28 billion. Wall […]

Bruker (NASDAQ:BRKR – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $2.79-2.84 for the period, compared to the consensus EPS estimate of $2.71. The company issued revenue guidance of $3.29-3.35 billion, compared to the consensus revenue estimate of $3.28 billion. Bruker Trading Down 0.1 % Bruker stock […]

Bruker (NASDAQ:BRKR – Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.07, Briefing.com reports. Bruker had a return on equity of 29.94% and a net margin of 14.41%. The firm had revenue of $721.70 […]

Buckhead Capital Management LLC purchased a new position in shares of Bruker Co. (NASDAQ:BRKR – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 22,244 shares of the medical research company’s stock, valued at approximately $1,634,000. Several other institutional investors have also bought and sold shares of the stock. Lindbrook Capital […]

Shares of Bruker Co. (NASDAQ:BRKR – Get Free Report) have been given an average recommendation of “Hold” by the seven brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. […]

Bruker (NASDAQ:BRKR – Get Free Report) had its price target upped by research analysts at The Goldman Sachs Group from $66.00 to $74.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a “sell” rating on the medical research company’s stock. The Goldman Sachs Group’s target price points to a potential downside […]

Bruker (NASDAQ:BRKR – Get Free Report) had its price target upped by The Goldman Sachs Group from $66.00 to $74.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “sell” rating on the medical research company’s stock. The Goldman Sachs Group’s target price would suggest a potential downside of 16.58% […]

Vaughan Nelson Investment Management L.P. grew its holdings in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 62.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 315,210 shares of the medical research company’s stock after buying an additional 121,201 shares during the period. Vaughan Nelson Investment Management L.P.’s holdings in Bruker were […]

Bruker Co. (NASDAQ:BRKR – Get Free Report)’s stock price hit a new 52-week high on Thursday . The stock traded as high as $94.36 and last traded at $94.27, with a volume of 87205 shares traded. The stock had previously closed at $92.97. Analyst Ratings Changes Several equities analysts recently weighed in on BRKR shares. […]

Bruker Co. (NASDAQ:BRKR – Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $88.28 and last traded at $87.75, with a volume of 195938 shares changing hands. The stock had previously closed at $86.43. Analyst Ratings Changes Several research analysts have commented on the […]